Kessler Foundation
kesslerfoundation.orgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
172
Active
48
Phase 3
0
Total enrollment
8,910
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Sham tDCS + elbow flexion exercise | — | — | — | — | — | 1 |
Next readouts
- 2027-08-31
Top conditions
- Traumatic Brain Injury35
- Multiple Sclerosis26
- Stroke22
- Spinal Cord Injuries18
- Spinal Cord Injury12
- Spinal Cord Diseases6
- Cognitive Impairment6
- SCI - Spinal Cord Injury6
Frequently asked questions about Kessler Foundation
- How many clinical trials does Kessler Foundation have on ClinicalTrials.gov?
- Kessler Foundation is listed as the lead sponsor on 172 clinical trials in ClinicalTrials.gov, 48 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Kessler Foundation's trials are in Phase 3?
- 0 of Kessler Foundation's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Kessler Foundation focus on?
- Kessler Foundation's most-studied conditions on ClinicalTrials.gov are Traumatic Brain Injury, Multiple Sclerosis, Stroke, Spinal Cord Injuries, Spinal Cord Injury.
- When are Kessler Foundation's next clinical trial readouts?
- Kessler Foundation has 1 upcoming primary-completion readout tracked here; the soonest is “tDCS for Cancer-Related Fatigue and Weakness”, expected around 2027-08-31.